Skye Bioscience, Inc. - Common Stock, par value $0.001 (SKYE)

CUSIP: 83086J200

Q4 2025 13F Holders as of 31 Dec 2025

Security type / class
Equity / Common Stock, par value $0.001
Total 13F shares
16,131,666
Total 13F value
$12,093,567
Holder snapshot 6 visible 7 signals
Share change
-3,751,499
Put/Call ratio
28%
SEC-reported price per share
$0.75
Number of holders
49
Value change
-$11,627,173
Number of buys
20
Open additional details 1 more signal available
Number of sells
31
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
33,945,050

Security key

83086J200

Report period

Q4 2025

Institutions

49

Top holders

10

SKYE full security history Ownership snapshot Full 13F holder table Newer quarter: Q1 2026 Previous quarter: Q3 2025 Skye Bioscience, Inc. SEC filings Skye Bioscience, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of SKYE - Skye Bioscience, Inc. - Common Stock, par value $0.001 (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
5AM Partners VII, LLC
Disclosed value leader
5AM Venture Management, LLC
Comparable rows
15/15
Latest evidence
30 Sep 2025
3/4/5 13D/G 13F Lead comparable stake: 34% 13D/G row: 5AM Partners VII, LLC Showing 1-6 of 15 holder rows.

Quick read

5AM Partners VII, LLC leads the comparable SEC ownership view at 34%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens 5AM Partners VII, LLC's linked filing trail.
Comparable ownership Top 5
5AM Partners VII, LLC 34%
SPHERA FUNDS MANAGEMENT LTD. 4.8%
Schonfeld Strategic Advisors LLC 3.6%
5AM Venture Management, LLC 29%
Versant Venture Management, LLC 5.9%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
5AM Partners VII, LLC
3/4/5 13D/G
10%+ Owner · Andrew J. Schwab
3/4/5 13D/G
34%
from 13D/G
$34,663,397
9,681,763 shares
 -$800,549 21 Aug 2025
SPHERA FUNDS MANAGEMENT LTD.
13D/G 13F
Company
13D/G 13F
4.8%
$2,952,706
1,476,353 shares
 $0 31 Mar 2025
Schonfeld Strategic Advisors LLC
13F 13D/G
Company
13F 13D/G
3.6%
from 13D/G
$4,665,748
1,187,214 shares
 — 30 Sep 2025
5AM Venture Management, LLC
13F
Company
13F
29%
$38,049,329
9,681,763 shares
 — 30 Sep 2025
Versant Venture Management, LLC
13F
Company
13F
5.9%
$7,890,277
2,007,704 shares
 — 30 Sep 2025
BAKER BROS. ADVISORS LP
13F
Company
13F
4.3%
$5,701,007
1,450,638 shares
 — 30 Sep 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
49
Shares
16,131,666
Rows available
49
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 holders
56
Q4 2025 holders
49
Holder diff
-7
Investor Q3 2025 Shares Q4 2025 Shares Share Diff Share Chg % Q3 2025 value Q4 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .